-
Who we are
Who we are
We are a biotechnology company committed to helping address serious infectious diseases globally through the discovery and development of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
-
What we do
What we do
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
Latest UpdatesStay current with Novavax news as we make progress in discovering and developing innovative vaccines to help protect against serious infectious diseases.
-
Blog
Blog
Novavax is committed to accelerating the development of new and promising vaccines and sharing information based on years of study and experience.
MEDICAL PROFESSIONAL HUB
Novavax is a biotechnology company committed to helping to address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world.
Resources prepared for you to answer your questions
Global authorization site of Novavax COVID-19 Vaccine (recombinant, adjuvanted)
Product summary for healthcare professionals, patient information, expiry date checker, FAQs, and more
Global medical information site
Ask medical questions, report adverse events, and report product quality complaints
Publications
Source in-depth information about our research areas
Matrix-M adjuvant production process
Our vaccine uses saponins, from the Quillaja saponaria tree, to help generate a robust immune response.
Producing a Novavax vaccine
Learn more about the 6 step process used to manufacture our vaccine.
Investigator-Initiated Studies (IIS)
The Novavax IIS program supports clinical and non-clinical research that addresses important unmet scientific or medical needs aligned with Novavax's areas of interest. Support for an approved IIS may include funding, Novavax product, or both.
Become a clinical trial site with Novavax
If you are interested in participating as a clinical trial site with Novavax, please complete the site questionnaire.